Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Oncotarget|October 14, 2015
Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic miceYou-Jun Li, Guodong Liu, Lei Xia, et al.
Molecular Cancer Research : MCR|March 8, 2013
mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of β1 integrin functionYou-Jun Li, Guodong Liu, Yanmei Li, et al.
The Journal of Clinical Investigation|September 8, 2022
The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host diseaseSteven D Schutt, Yongxia Wu, Arjun Kharel, et al.
Biochemical Pharmacology|June 26, 2026
Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemiaJian Gao, Fen Tian, Yao Tang, et al.
Cancer Cell|January 18, 2005
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesisYuval Shaked, Francesco Bertolini, Shan Man, et al.
The FEBS Journal|November 3, 2018
Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemiaJialei Song, Chunmao Yuan, Jue Yang, et al.
Oncotarget|October 17, 2015
MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancerMitchell E Menezes, Xue-Ning Shen, Swadesh K Das, et al.
Cell Reports|April 5, 2018
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast CancerJeff C Liu, Letizia Granieri, Mariusz Shrestha, et al.
Oncotarget|January 5, 2017
A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesisTangjingjun Liu, Yao Yao, Gang Zhang, et al.
Nature Communications|April 15, 2020
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapyPhilip E D Chung, Deena M A Gendoo, Ronak Ghanbari-Azarnier, et al.
Pageof 10